Natixis’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-31,186
| Closed | -$433K | – | 1134 |
|
|
2024
Q1 | $433K | Hold |
31,186
| – | – | ﹤0.01% | 633 |
|
|
2023
Q4 | $517K | Hold |
31,186
| – | – | ﹤0.01% | 589 |
|
|
2023
Q3 | $505K | Hold |
31,186
| – | – | ﹤0.01% | 590 |
|
|
2023
Q2 | $468K | Hold |
31,186
| – | – | ﹤0.01% | 636 |
|
|
2023
Q1 | $444K | Buy |
31,186
+5,000
| +19% | +$71.3K | ﹤0.01% | 629 |
|
|
2022
Q4 | $354K | Buy |
+26,186
| New | +$354K | ﹤0.01% | 700 |
|